← Open Payments lookup

SHALINI PAPPACHAN: Open Payments

NPI 1598217317 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$582 in 9 payments from 7 companies in 2025. Trend: 2023 $899 · 2024 $583 · 2025 $582

Food & beverage: $582
CompanyPaymentsAmount
Amgen Inc.3$185
Stemline Therapeutics Inc.1$111
SpringWorks Therapeutics, Inc.1$100
Gilead Sciences, Inc.1$89
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$37
BridgeBio Pharma, Inc.1$34
Novartis Pharmaceuticals Corporation1$25

Products named: REPATHA, Orserdu, OGSIVEO, Trodelvy, LifeVest, Attruby, LEQVIO.

Industry payments across TX — which companies pay providers there.